1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Speedel Pharma Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy SPP301 - Diabetic Nephropathy | Phase 3 | Terminated | Speedel Pharma Ltd. | 2364 | 2005-07-01 | 2007-10-05 |
Diabetic Nephropathies (1) · Kidney Failure, Chronic (1)
Avosentan (1)
United States (1)
2005 (1)